Research programme: GPCR agonists - Yuhan CorporationAlternative Names: YH 18406; YH-NCE1 - diabetes
Latest Information Update: 15 Dec 2014
At a glance
- Originator Yuhan
- Class Small molecules
- Mechanism of Action G protein-coupled receptor agonists; GPR119 protein agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Diabetes mellitus
Most Recent Events
- 15 Dec 2014 Preclinical development is ongoing in South Korea
- 22 Aug 2012 Preclinical trials in Diabetes mellitus in South Korea (unspecified route)